PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Urology, Boston Children\'s Hospital, Boston, MA 02115, USA; Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA. Electronic address: songhai.tian@childrens.harvard.edu.\', \'Department of Urology, Boston Children\'s Hospital, Boston, MA 02115, USA; Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA; Department of Nephrology, The First Hospital of Jilin University, Changchun, 130021, China.\', \'Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02115, USA.\', \'Department of Urology, Boston Children\'s Hospital, Boston, MA 02115, USA; Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA.\', \'Department of Urology, Boston Children\'s Hospital, Boston, MA 02115, USA; Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA. Electronic address: min.dong@childrens.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-1247(22)00209-110.1016/j.celrep.2022.110476
?:doi
?:hasPublicationType
?:journal
  • Cell reports
is ?:pmid of
?:pmid
?:pmid
  • 35263584
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.552
?:rankingScore_hIndex
  • 92
is ?:relation_isRelatedTo_publication of
?:title
  • Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all